Latest AI and machine learning research in oncology/hematology for healthcare professionals.
Hepatocellular carcinoma (HCC) is an exceedingly aggressive form of cancer that often carries a poor prognosis, especially when it is complicated by the presence of microvascular invasion (MVI). Identifying patients at high risk of MVI is crucial for personalized treatment strategies. Utilizing the single-cell RNA-sequencing dataset (GSE242889) of HCC, we identified malignant cell subtypes associa...
To assess the efficacy of a deep learning platform for managing symptoms in chemotherapy patients, aiming to enhance their quality of life. A non-randomized controlled trial was conducted from September 2022 to March 2024, involving 144 chemotherapy patients divided into intervention (n = 72) and control (n = 72) groups. The intervention group received the deep learning platform, whereas the contr...
BACKGROUND AND OBJECTIVE: Spread through air spaces (STAS) is an important factor in determining the aggressiveness and recurrence risk of lung cancer...
BACKGROUND: Thyroid cancer is a prevalent malignancy requiring accurate subtype identification for effective treatment planning and prognosis evaluati...
The integration of artificial intelligence (AI) into oncology promises to revolutionize cancer care. In this Review, we discuss ten AI hallmarks in pr...
The quantification of circulating tumour DNA (ctDNA) in blood enables non-invasive surveillance of cancer progression. Here we show that a deep-learni...
RATIONALE AND OBJECTIVES: To investigate a computed tomography (CT)-based multiparameter deep learning-radiomic model (DLRM) for predicting the preope...
Automatic clinical tumor volume (CTV) delineation is pivotal to improving outcomes for interstitial brachytherapy cervical cancer. However, the promin...
Breast cancer (BC) remains a predominant and deadly cancer in women worldwide. By 2040, projections indicate that more than 3 million new cases of bre...
Cancer is a severe threat to public health. Early diagnosis of disease is critical, but the lack of experts in this field, the personal assessment pro...
Cervical cancer (CC) is the leading cancer, which mainly affects women worldwide. It generally occurs from abnormal cell evolution in the cervix and a...
Whole-body bone scan (WBS) is usually used as the effective diagnostic method for early-stage and comprehensive bone metastases of breast cancer. WBS ...
BACKGROUND: Apart from rare cases such as lymphomas, germ cell tumors, neuroendocrine neoplasms, and thymic hyperplasia, thymic mass lesions (TMLs) ar...
BACKGROUND: Large language models may form the basis of clinical decision support tools to improve rates of guideline concordant care for pancreatic d...
Cancer is a multifaceted disease that results from co-mutations of multi biological molecules. A promising strategy for cancer therapy involves in exp...
Homologous recombination deficiency (HRD) is a well-recognized important biomarker in determining the clinical benefits of platinum-based chemotherapy...
Drug repositioning has emerged as a promising strategy for identifying new therapeutic applications for existing drugs. In this study, we present DRGB...
Prostate cancer screening often relies on cost-intensive MRIs and invasive needle biopsies. Transrectal ultrasound imaging, as a more affordable and n...
Low-dose computed tomography (LDCT) is a specialized CT scan with a lower radiation dose than normal-dose CT. However, the reduced radiation dose can ...
Accurate breast tumor segmentation in ultrasound images is a crucial step in medical diagnosis and locating the tumor region. However, segmentation fa...